Applying to Clinical Trial: Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Contact this trialFirst, we need to learn more about you.

Monoclonal Antibodies

Ligelizumab for Chronic Urticaria

Recruiting1 awardPhase 3

White Marsh, Maryland

This trial will test if the drug ligelizumab is effective and safe for people with chronic inducible urticaria who haven't been helped by H1-antihistamines.

Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.

We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our and .

Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.

By clicking start, you agree to our